IL147731A0 - Peptide pharmaceutical formulations - Google Patents

Peptide pharmaceutical formulations

Info

Publication number: IL147731A0
Authority: IL; Israel
Prior art keywords: pharmaceutical formulations; peptide pharmaceutical; peptide; formulations; pharmaceutical
Prior art date: 2000-05-19

Application number

IL14773101A

Other languages

English (en)

Original Assignee

Bionebraska Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-19

Filing date

2001-05-17

Publication date

2002-08-14

2001-05-17 Application filed by Bionebraska Inc filed Critical Bionebraska Inc

2001-05-17 Priority claimed from PCT/US2001/015872 external-priority patent/WO2001087322A2/en

2002-08-14 Publication of IL147731A0 publication Critical patent/IL147731A0/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

IL14773101A 2000-05-19 2001-05-17 Peptide pharmaceutical formulations IL147731A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20526200P	2000-05-19	2000-05-19
PCT/US2001/015872 WO2001087322A2 (en)	2000-05-17	2001-05-17	Peptide pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
IL147731A0 true IL147731A0 (en)	2002-08-14

Family

ID=22761491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14773101A IL147731A0 (en)	2000-05-19	2001-05-17	Peptide pharmaceutical formulations

Country Status (4)

Country	Link
EP (1)	EP1301200A2 (de)
JP (1)	JP2004513069A (de)
AU (1)	AU785444B2 (de)
IL (1)	IL147731A0 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1506786B1 (de)	2002-05-21	2016-11-23	Daiichi Sankyo Company, Limited	Medizinische, ghrelin enthaltende zusammensetzungen
KR101149454B1 (ko)	2004-08-24	2012-05-25	간가와 겐지	생리활성 펩티드의 액상 제제
KR100700869B1 (ko) *	2005-06-03	2007-03-29	재단법인 목암생명공학연구소	Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물
CN103405753B (zh) *	2013-08-13	2016-05-11	上海仁会生物制药股份有限公司	稳定的促胰岛素分泌肽水针药物组合物
CN107952064B (zh) *	2016-10-14	2023-10-20	江苏豪森药业集团有限公司	含有聚乙二醇洛塞那肽的药物制剂及其制备方法
US20200289621A1 (en)	2017-09-22	2020-09-17	Asahi Kasei Pharma Corporation	Teriparatide-containing liquid pharmaceutical composition having excellent stability
JP2019060866A (ja) *	2017-09-22	2019-04-18	旭化成ファーマ株式会社	液状医薬組成物の体内動態を予測する方法
CA3075984C (en)	2017-09-22	2024-10-01	Asahi Kasei Pharma Corporation	LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE WITH EXCELLENT PHARMACOKINETIC AND/OR SAFETY PROPERTIES
ES3017234T3 (en) *	2019-09-25	2025-05-12	Lumosa Therapeutics Co Ltd	Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0383931A (ja) *	1989-08-29	1991-04-09	Sumitomo Pharmaceut Co Ltd	低刺激性ｇｒｆ経鼻投与製剤
UA65549C2 (uk) *	1996-11-05	2004-04-15	Елі Ліллі Енд Компані	Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
ZA9811127B (en) *	1997-12-09	2000-07-11	Lilly Co Eli	Stabilized teriparatide solutions.
WO1999047160A1 (en) *	1998-03-13	1999-09-23	Novo Nordisk A/S	Stabilized aqueous peptide solutions
EP1064934A1 (de) *	1999-06-30	2001-01-03	Applied Research Systems ARS Holding N.V.	Gefriergetrocknete GRF-enthaltende Arzneimittel

2001
- 2001-05-17 IL IL14773101A patent/IL147731A0/xx unknown
- 2001-05-17 EP EP01941488A patent/EP1301200A2/de not_active Withdrawn
- 2001-05-17 AU AU74839/01A patent/AU785444B2/en not_active Ceased
- 2001-05-17 JP JP2001583789A patent/JP2004513069A/ja active Pending

Also Published As

Publication number	Publication date
AU7483901A (en)	2001-11-26
EP1301200A2 (de)	2003-04-16
JP2004513069A (ja)	2004-04-30
AU785444B2 (en)	2007-06-14

Similar Documents

Publication	Publication Date	Title
GB0319041D0 (en)	2003-09-17	Pharmaceutical Formulations
GB0001621D0 (en)	2000-03-15	Pharmaceutical compositions
AU6219601A (en)	2001-10-30	Pharmaceutical compositions
GB0009584D0 (en)	2000-06-07	Pharmaceutical compositions
AU8576801A (en)	2002-01-02	Pharmaceutical compositions
GB0121715D0 (en)	2001-10-31	Pharmaceutical formulations
GB2380129B (en)	2004-08-11	Pharmaceutical formulations
GB0103638D0 (en)	2001-03-28	Pharmaceutical formulations
GB0120701D0 (en)	2001-10-17	Pharmaceutical formulations
AU1390002A (en)	2002-03-22	Pharmaceutical compositions
GB0008485D0 (en)	2000-05-24	Pharmaceutical compositions
GB0105560D0 (en)	2001-04-25	Pharmaceutical formulations
EP1173216A4 (de)	2004-09-29	Pharmazeutische formulierungen
IL147731A0 (en)	2002-08-14	Peptide pharmaceutical formulations
AU2001296389A1 (en)	2002-04-08	Stable peptide formulations
GB0014851D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB9906126D0 (en)	1999-05-12	Pharmaceutical formulations
GB9930578D0 (en)	2000-02-16	Pharmaceutical formulations
GB0014892D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB0014947D0 (en)	2000-08-09	Novel pharmaceutical formulation
GB0014883D0 (en)	2000-08-09	Novel pharmaceutical formulation
IL135442A0 (en)	2001-05-20	Peptides and pharmaceutical compositions comprising them
GB0124455D0 (en)	2001-12-05	Pharmaceutical formulations
GB0021487D0 (en)	2000-10-18	Pharmaceutical
GB0014869D0 (en)	2000-08-09	Novel pharmaceutical formulation